Linc AB
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LINC.ST research report →
Companylinc.se
Linc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment.
- CEO
- Karl Tobieson
- IPO
- 2021
- Employees
- 2
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $4.33B
- P/E
- 10.31
- P/S
- 710.80
- P/B
- 1.02
- EV/EBITDA
- 9.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -106.08%
- Op Margin
- 7055.59%
- Net Margin
- 6892.05%
- ROE
- 9.64%
- ROIC
- 9.54%
Growth & Income
- Revenue
- $9.70M · 0.00%
- Net Income
- $-399,647,000 · -130.70%
- EPS
- $-6.90 · -130.69%
- Op Income
- $-422,822,000
- FCF YoY
- -100.00%
Performance & Tape
- 52W High
- $83.60
- 52W Low
- $58.90
- 50D MA
- $72.47
- 200D MA
- $70.63
- Beta
- 0.71
- Avg Volume
- 39.98K
Get TickerSpark's AI analysis on LINC.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LINC.ST Coverage
We haven't published any research on LINC.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LINC.ST Report →